{"entity":{"type":"insider","cik":"0001325719","url":"/insider/0001325719","json_url":"/insider/0001325719.json","name":"Bahcall Safi R","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":12,"first":"2007-11-26","last":"2013-11-15","span_basis":"filed_date"},"name_variants":[{"name":"Bahcall Safi R","source":"filing","n_filings":12,"first_seen":"2007-11-26","last_seen":"2013-11-15"}],"transactions":[{"id":4588666,"accession":"0001179110-13-016610","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-13-016610","line_url":"/filing/0001179110-13-016610#line-1","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"SYNTA PHARMACEUTICALS CORP","issuer_ticker":"SNTA","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001325719","owner_name":"Bahcall Safi R","owner_display_name":"Bahcall Safi R","owner_url":"/insider/0001325719","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":3.75,"price_display":"3.75","price_state":"stated","total_value":75000.0,"total_display":"75,000.00","total_whole":"75,000","shares_owned_after":2053135.0,"shares_owned_after_display":"2,053,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-13","filed_date":"2013-11-15","scope":"insider"},{"id":5326404,"accession":"0001179110-13-011095","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-13-011095","line_url":"/filing/0001179110-13-011095#line-1","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"SYNTA PHARMACEUTICALS CORP","issuer_ticker":"SNTA","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001325719","owner_name":"Bahcall Safi R","owner_display_name":"Bahcall Safi R","owner_url":"/insider/0001325719","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":5.0299,"price_display":"5.03","price_state":"stated","total_value":50299.0,"total_display":"50,299.00","total_whole":"50,299","shares_owned_after":2033135.0,"shares_owned_after_display":"2,033,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-28","filed_date":"2013-07-01","scope":"insider"},{"id":5196928,"accession":"0001179110-13-010743","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-13-010743","line_url":"/filing/0001179110-13-010743#line-1","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"SYNTA PHARMACEUTICALS CORP","issuer_ticker":"SNTA","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001325719","owner_name":"Bahcall Safi R","owner_display_name":"Bahcall Safi R","owner_url":"/insider/0001325719","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":4.1187,"price_display":"4.12","price_state":"stated","total_value":82374.0,"total_display":"82,374.00","total_whole":"82,374","shares_owned_after":2023135.0,"shares_owned_after_display":"2,023,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-21","filed_date":"2013-06-24","scope":"insider"},{"id":4814351,"accession":"0001179110-13-010426","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-13-010426","line_url":"/filing/0001179110-13-010426#line-1","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"SYNTA PHARMACEUTICALS CORP","issuer_ticker":"SNTA","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001325719","owner_name":"Bahcall Safi R","owner_display_name":"Bahcall Safi R","owner_url":"/insider/0001325719","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.055,"price_display":"4.06","price_state":"stated","total_value":40550.0,"total_display":"40,550.00","total_whole":"40,550","shares_owned_after":2003135.0,"shares_owned_after_display":"2,003,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-14","filed_date":"2013-06-17","scope":"insider"},{"id":5062746,"accession":"0001179110-13-009876","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-13-009876","line_url":"/filing/0001179110-13-009876#line-1","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"SYNTA PHARMACEUTICALS CORP","issuer_ticker":"SNTA","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001325719","owner_name":"Bahcall Safi R","owner_display_name":"Bahcall Safi R","owner_url":"/insider/0001325719","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.039,"price_display":"4.04","price_state":"stated","total_value":40390.0,"total_display":"40,390.00","total_whole":"40,390","shares_owned_after":1993135.0,"shares_owned_after_display":"1,993,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-06","filed_date":"2013-06-06","scope":"insider"},{"id":3411473,"accession":"0001179110-12-015902","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-12-015902","line_url":"/filing/0001179110-12-015902#line-1","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"SYNTA PHARMACEUTICALS CORP","issuer_ticker":"SNTA","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001325719","owner_name":"Bahcall Safi R","owner_display_name":"Bahcall Safi R","owner_url":"/insider/0001325719","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":7.12,"price_display":"7.12","price_state":"stated","total_value":71200.0,"total_display":"71,200.00","total_whole":"71,200","shares_owned_after":2373135.0,"shares_owned_after_display":"2,373,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-12","filed_date":"2012-11-13","scope":"insider"},{"id":2605776,"accession":"0001179110-12-010917","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-12-010917","line_url":"/filing/0001179110-12-010917#line-1","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"SYNTA PHARMACEUTICALS CORP","issuer_ticker":"SNTA","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001325719","owner_name":"Bahcall Safi R","owner_display_name":"Bahcall Safi R","owner_url":"/insider/0001325719","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":5.337,"price_display":"5.34","price_state":"stated","total_value":53370.0,"total_display":"53,370.00","total_whole":"53,370","shares_owned_after":2343135.0,"shares_owned_after_display":"2,343,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-29","filed_date":"2012-07-02","scope":"insider"},{"id":9121033,"accession":"0001179110-11-004911","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-11-004911","line_url":"/filing/0001179110-11-004911#line-1","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"SYNTA PHARMACEUTICALS CORP","issuer_ticker":"SNTA","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001325719","owner_name":"Bahcall Safi R","owner_display_name":"Bahcall Safi R","owner_url":"/insider/0001325719","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.45,"price_display":"4.45","price_state":"stated","total_value":22250.0,"total_display":"22,250.00","total_whole":"22,250","shares_owned_after":2333135.0,"shares_owned_after_display":"2,333,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-15","filed_date":"2011-03-15","scope":"insider"},{"id":7486096,"accession":"0001179110-10-010256","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-10-010256","line_url":"/filing/0001179110-10-010256#line-1","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"SYNTA PHARMACEUTICALS CORP","issuer_ticker":"SNTA","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001325719","owner_name":"Bahcall Safi R","owner_display_name":"Bahcall Safi R","owner_url":"/insider/0001325719","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.053,"price_display":"3.05","price_state":"stated","total_value":30530.0,"total_display":"30,530.00","total_whole":"30,530","shares_owned_after":2316586.0,"shares_owned_after_display":"2,316,586","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-06-10","filed_date":"2010-06-10","scope":"insider"},{"id":7191678,"accession":"0001179110-10-000892","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-10-000892","line_url":"/filing/0001179110-10-000892#line-1","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"SYNTA PHARMACEUTICALS CORP","issuer_ticker":"SNTA","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001325719","owner_name":"Bahcall Safi R","owner_display_name":"Bahcall Safi R","owner_url":"/insider/0001325719","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22222.0,"shares_display":"22,222","price_per_share":4.5,"price_display":"4.50","price_state":"stated","total_value":99999.0,"total_display":"99,999.00","total_whole":"99,999","shares_owned_after":2292747.0,"shares_owned_after_display":"2,292,747","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-08","filed_date":"2010-01-12","scope":"insider"},{"id":5677128,"accession":"0001179110-09-011745","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001179110-09-011745","line_url":"/filing/0001179110-09-011745","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"SYNTA PHARMACEUTICALS CORP","issuer_ticker":"SNTA","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001325719","owner_name":"Bahcall Safi R","owner_display_name":"Bahcall Safi R","owner_url":"/insider/0001325719","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.8504565,"price_display":"2.85","price_state":"stated","total_value":57009.13,"total_display":"57,009.13","total_whole":"57,009","shares_owned_after":2270525.0,"shares_owned_after_display":"2,270,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-06","filed_date":"2009-08-07","scope":"insider","n_lines":7},{"id":7597023,"accession":"0001179110-07-022177","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-07-022177","line_url":"/filing/0001179110-07-022177#line-1","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"SYNTA PHARMACEUTICALS CORP","issuer_ticker":"SNTA","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001325719","owner_name":"Bahcall Safi R","owner_display_name":"Bahcall Safi R","owner_url":"/insider/0001325719","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":7.8281,"price_display":"7.83","price_state":"stated","total_value":39140.5,"total_display":"39,140.50","total_whole":"39,141","shares_owned_after":2250525.0,"shares_owned_after_display":"2,250,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-26","filed_date":"2007-11-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":18,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001157601","name":"SYNTA PHARMACEUTICALS CORP","url":"/issuer/0001157601","role":"Director, Officer (President and CEO)","n_filings":12,"first_seen":"2007-11-26","last_seen":"2013-11-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001325719","retrieved_at":"2026-08-27T05:00:51+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}